Showing results (11-20 of 176) with videos related to
Sort By:
Pageof 18
Seminars in Oncology|August 8, 2006
Novel agents that target tublin and related elementsEric K Rowinsky, Emiliano CalvoCurrent Oncology Reports|February 19, 2005
Approaches to optimize the use of monoclonal antibodies to epidermal growth factor receptorEmiliano Calvo, Eric K RowinskyCancer Treatment Reviews|March 18, 2022
First-line immune checkpoint inhibitors in advanced or metastatic renal cell carcinoma with sarcomatoid featuresMário Fontes-Sousa, Emiliano CalvoClinical Lung Cancer|January 11, 2005
Effect of epidermal growth factor receptor mutations on the response to epidermal growth factor receptor tyrosine kinase inhibitors: target-based populations for target-based drugsEmiliano Calvo, Eric K RowinskyAnti-Cancer Drugs|December 22, 2010
Non-clear cell advanced kidney cancer: is there a gold standard?Pedro Sánchez, Emiliano Calvo, Ignacio DuránThe Lancet Regional Health. Europe|May 8, 2026
Oncolytic viruses and neoantigen vaccines: opportunities and challenges in priming antitumour immunityAndré Mansinho, Joana Albuquerque, Emiliano CalvoCancer Treatment Reviews|July 27, 2012
What is the optimal therapy for patients with metastatic renal cell carcinoma who progress on an initial VEGFr-TKI?Emiliano Calvo, Alain Ravaud, Joaquim BellmuntOncotargets and Therapy|July 10, 2010
Multiple roles and therapeutic implications of Akt signaling in cancerEmiliano Calvo, Victoria Bolós, Enrique GrandeEuropean Journal of Cancer (Oxford, England : 1990)|March 6, 2014
Controversies in renal cell carcinoma: treatment choice after progression on vascular endothelial growth factor-targeted therapyEmiliano Calvo, Viktor Grünwald, Joaquim BellmuntInvestigational New Drugs|August 10, 2022
Phase I study of lurbinectedin in combination with weekly paclitaxel with or without bevacizumab in patients with advanced solid tumorsEmiliano Calvo, Cristiana Sessa, Guilherme Harada, et al.Pageof 18